ESTROGEN RECEPTOR STATUS

Clinical trials for ESTROGEN RECEPTOR STATUS explained in plain language.

Never miss a new study

Get alerted when new ESTROGEN RECEPTOR STATUS trials appear

Sign up with your email to follow new studies for ESTROGEN RECEPTOR STATUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for Tough-to-Treat breast cancer: Two-Drug combo tested

Disease control Completed

This study tested whether adding the hormone therapy fulvestrant to a new drug called alisertib works better than alisertib alone for women with advanced breast cancer that has spread and stopped responding to standard hormone treatments. It involved 96 postmenopausal women. Rese…

Matched conditions: ESTROGEN RECEPTOR STATUS

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

ESTROGEN RECEPTOR STATUS

Get alerted when new ESTROGEN RECEPTOR STATUS trials appear

New hope for Tough-to-Treat breast cancer: Two-Drug combo tested